about
New Mexico's capacity for increasing the prevalence of colorectal cancer screening with screening colonoscopies.Randomized single blind trial of two low-volume bowel preparations for screening computed tomographic colonography.Opportunistic screening of hospital staff using primary colonoscopy: participation, discomfort and willingness to repeat the procedure.Individualizing colonoscopy screening by sex and race.Determinants of participation in colonoscopic screening by siblings of colorectal cancer patients in France.Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis.Three-dimensional MR and axial CT colonography versus conventional colonoscopy for detection of colon pathologies.Colorectal cancer screening: now is the time.Early detection for colorectal cancer: new aspects in fecal occult blood screening.The effect of disease prevention and health promotion on workplace productivity: a literature review.Cost effectiveness of detecting Barrett's cancer.The limited incorporation of economic analyses in clinical practice guidelines.Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable.Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policyAs tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasiaA prediction model for colon cancer surveillance data.Computed tomographic colonography (CTC): Possibilities and limitations of clinical application in colorectal polyps and cancer.The case for universal screening colonoscopy.Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer.Physician-patient communication about colorectal cancer screening.A cost analysis of colonoscopy using microcosting and time-and-motion techniques.Screening techniques for prevention and early detection of colorectal cancer in the average-risk population.Patient satisfaction with colonoscopy: a literature review and pilot studyColorectal cancer screening tests: pros and cons, and for whom?Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation.How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice surveyColonoscopy uptake for high-risk individuals with a family history of colorectal neoplasia: A multicenter, randomized trial of tailored counseling versus standard information.Positive cost effectiveness of early diagnosis of colorectal cancer.Understanding the Effects of Competition for Constrained Colonoscopy Services with the Introduction of Population-level Colorectal Cancer Screening.Do individuals with a family history of colorectal cancer adhere to medical recommendations for the prevention of colorectal cancer?Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the Will Rogers phenomenon on costs.The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40-80 years.Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.Review article: faecal occult blood testing for colorectal cancer.Effectiveness and cost-effectiveness of colorectal cancer screening: Selecting the ideal strategy.Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer.Is routine screening for colorectal cancer justifiable? These gastroenterologists say YES!Current standards and new developments of colorectal polyp management and resection techniques.Seasonal variation of participation in colorectal neoplasia screening by colonoscopy or CT colonography.
P2860
Q25255679-493AE778-16BD-4604-8D5A-A1EC2A77D260Q33152234-7B808DCB-83DA-4C14-A192-3FD644309255Q33452297-56AFC5F0-6E8D-4929-98D6-D206504D1B78Q33588581-0CFE72F2-3FE2-425E-87BF-8AC38D0B1751Q33625525-E29BC8FA-F655-4228-AC2B-F30E2111EBAEQ33774326-13036D14-ED2A-4426-962D-1DAB9592D10CQ33868822-67F37E33-0D49-4ACA-B553-3B4B0CA4CFFEQ33954705-BA2A3685-F6BE-4CF4-B2EE-BB9909F39BE9Q34087856-D87146B4-9C5E-4917-8D2A-A70B3120CF56Q34193795-208F7928-9EAC-4937-B0B9-4F3BBB2EE714Q34410091-B955E66C-BC5E-4735-9F19-5F2A15E6D24FQ34585520-17EBE1C6-33AB-446F-B2BB-1B603281CC96Q34939027-3A0EAB38-37A2-4749-B45A-13AE1D320B2AQ35173359-816EFCB9-D333-4367-85DA-40D511D55930Q35206019-8E72E283-2055-467F-8937-2300D8AC7582Q35597092-A14DE637-4362-492C-A606-58F90F5F36E7Q35731966-D182A3D4-28CD-4428-889C-C04B0769EC99Q36101821-85010DC6-3958-4221-BE31-BE163240FEF7Q36172866-5C84795F-EBFF-4E33-9E39-E67EFEA2C3D3Q36416846-967110F5-29C4-4803-B953-E73C1CCF94F4Q36552245-167B9471-572B-46F3-A38C-EC98A6F38985Q37077216-AC90082E-3D6C-4630-863E-76A794448F4CQ37223172-32B3663D-BB73-4419-8F8B-7ED0D44D90D7Q37345866-66E3E6A4-05F0-49C7-8E54-493994095E8AQ37630575-3C6BFE39-257C-4508-BC45-3629B4EDD67DQ37661469-F0519058-0FE5-424B-80DB-2D71A451EDFCQ37726636-D4466ED4-4521-4AF7-BCBF-8313F219FC73Q38476197-81A9A2A4-D499-4FBA-82EA-6E40BDAFE709Q39342406-AD55F48A-B2FF-4068-B990-233C45A265FAQ39441832-6C6FA597-418C-43BB-9091-64218AE64766Q39508977-4835697B-BF59-45E5-9034-D333AD5C8627Q40353447-39AF3000-147E-44EE-B8EC-F26F1A1132B5Q46128710-631ABD7A-8D69-4C04-854E-E8FB739895B8Q46499679-BFC66562-58A7-40B9-A5CE-3535D4E56FC8Q49614065-72B00F9A-A125-4C4F-AC3C-EAB526301D80Q50137985-D0E5F866-1453-4955-B4C8-5E21D853B835Q50623434-0E63D3A2-AF88-4B7E-9100-94B5A419E152Q50672338-7A39EF0B-F7ED-41CB-BB04-C4DA00F99039Q53531726-704FFA1C-C2F2-4C30-A432-91A80A66FE4E
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Cost-effectiveness model for colon cancer screening.
@en
type
label
Cost-effectiveness model for colon cancer screening.
@en
prefLabel
Cost-effectiveness model for colon cancer screening.
@en
P1433
P1476
Cost-effectiveness model for colon cancer screening.
@en
P2093
Lieberman DA
P304
P356
10.1016/0016-5085(95)90744-0
P407
P577
1995-12-01T00:00:00Z